Scisparc and Clearmind Secure Patent for Combination Therapy Targeting Obesity and Metabolic Syndrome Scisparc and Clearmind have announced a...

Cormedix’s acquisition of Melinta Therapeutics for $300 million, plus potential milestones and royalties, marks a decisive shift in the...

Pure Harvest Corporate Group, Inc. (PHCG) has achieved a significant milestone by eliminating all debt from its balance sheet....

Teva Pharmaceuticals has secured FDA approval for Ajovy (fremanezumab) as a preventative treatment for episodic migraine in children and...

Omass Therapeutics, a UK-based biotech specializing in targeting complex protein ecosystems, has appointed Carol A. Schafer as Non-Executive Director...

Nxera Pharma is boldly expanding its pipeline beyond partnerships into a wholly owned portfolio of next-generation obesity and metabolic...

TG Therapeutics Reports Strong Q2 2025 Briumvi Sales, Raises Full-Year Guidance TG Therapeutics announced impressive second-quarter 2025 results, driven...

Connect, a cornerstone of San Diego’s life science and technology ecosystem, has appointed James Zanewicz as its new CEO....

Artelo Biosciences is making a bold move, becoming the first publicly traded pharmaceutical company to adopt Solana (SOL) as...

Kura Oncology’s recent granting of stock options to 35 new employees, while seemingly routine, signals a strategic shift for...